The Welch Allyn RetinaVue care delivery model enables simple and affordable4 diabetic retinopathy screenings within primary care settings. With teleretinal programs, healthcare organizations and payors can help reduce costs2, improve care3, and close vital gaps in diabetic care.1


Arrange a no-obligation consultation to learn more about the RetinaVue solution.


Please download the payor sell sheet to learn more about RetinaVue care delivery model.

Improve star ratings and HCC risk factors.

Patients living with diabetes should be examined for complications on an annual basis, but only 60% comply7. Get the details on how RetinaVue care delivery model can help you close gaps1 and improve Star Ratings8 by enabling Primary Care Physicians to deliver diabetic retinopathy screenings at the point of patient care.


Improve HEDIS, STAR and HCC Risk Factors by Closing Care Gaps 1

Intercepting patients during routine primary care office visits with a teleretinal program, such as the RetinaVue care delivery model can help providers achieve up to 90% documented compliance with diabetic retinal exams in just 12 months.1

The RetinaVue care delivery model supports value-based care and quality programs - and more importantly, the opportunity to save more patients’ vision. Learn more in our eBook, The Solution is in Sight, The Complete Guide to a Successful Teleretinal Program.


Teleretinal programs can achieve up to 90% documented compliance with diabetic retinal exams in just 12 months.1

Welch Allyn® RetinaVue® 700 Imager

Woman Checking RetinaVue700

Help Save Vision for Patients Living with Diabetes6 in Primary Care

Diabetic retinopathy is the leading cause of blindness in working-age adults.5


95% of vision loss due to diabetic retinopathy can be prevented with early detection and treatment.6

RetinaVue Care Delivery Model

Help preserve the vision of your patients living with diabetes with a simple eye exam, that takes minutes to complete, for diabetic retinopathy detection during routine primary care visits. Baxter delivers the three keys to a successful teleretinal program:

Simple and Affordable Hardware

Simple and Affordable Hardware

Secure Software Network

Secure Software Network

Nationwide Services and Support

Nationwide Services and Support



Request A Virtual Demo

Request a demo of the RetinaVue care delivery model by completing the form.

Welch Allyn® RetinaVue® 700 Imager
  1. Mansberger SL, Gleitsmann K, Gardiner S, et al. Comparing the effectiveness of telemedicine and traditional surveillance in providing diabetic retinopathy screening examinations: A randomized controlled trial. Telemed J E Health. 2013 Dec; 19(12): 942-8.
  2. Newman, M. (2009) Fiscal Impact of AB 175: Analysis of the Cost Effectiveness of Store and Forward Teleophthalmology, Blue Sky Consulting Group for California Health Care Foundation,
  3. Liu Y, Swearingen R. Diabetic eye screening: knowledge and perspectives from providers and patients. Curr Diab Re. 2017 Aug 31; 17(10):94.
  4. Cuadros J, Bresnick G. Can commercially available handheld retinal cameras effectively screen diabetic retinopathy? J Diabetes Sci Technol. 2017 Jan; 11(1):135-7.
  5. Centers for Disease Control and Prevention. Vision Health Initiative (VHI). Published September 29, 2015. Updated June 3, 2020. Accessed September 9, 2022.
  6. New Treatment Options, Better Hope of Preventing Vision Loss from Diabetes I National Eye Institute. Published November 19, 2015. Accessed September 9, 2022.
  7. Diabetic Retinopathy Preferred Practice Pattern from the American Academy of Ophthalmology,, ISSN 0161-6420/19.
  8. Baxter. Rendr Care Achieves 5-Star Compliance for Diabetic Retinopathy Exams with WECLH ALLYN RETINAVUE Care Delivery Model. htttps:// Accessed July 17, 2023.

Rx Only: For safe and proper use of this device, please refer to Operating Manual
Baxter, Hillrom, RetinaVue and Welch Allyn are trademarks of Baxter International Inc. or its subsidiaries.
HEDIS is a trademark of the National Committee for Quality Assurance (NCQA).
US-FLC147-240073 (v1.0) 03/2024